STOCK TITAN

Tungray Technologies Financials

TRSG
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows Tungray Technologies (TRSG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRSG FY2024

Falling gross margin and sticky overhead turned a formerly self-funded operation into one leaning on external financing in FY2024.

From FY2022 to FY2024, gross margin compression from 56.7% to 43.7% mattered more than the sales decline because overhead did not fall with it. Operating cash flow swung from $3.6M to -$812K, showing the business stopped funding itself through operations before liquidity itself looked tight, which shifts the balance sheet from buffer to bridge.

Liquidity still buys time: FY2024 ended with $9.0M of cash and a current ratio of 1.9x, so near-term obligations do not appear to be forcing abrupt retrenchment. The more important shift is funding mix—cash has trended down while financing inflows increasingly substituted for internally generated cash, meaning balance-sheet flexibility is now supporting the operating model rather than simply sitting as excess protection.

Cost structure looks sticky: selling and administrative expense stayed around $4.6M even as revenue moved down to $12.8M, so weaker volume was not matched by similar cost relief. With R&D spending also higher, the company lost the fixed-cost absorption that had supported earlier profitability and free cash flow, making the deterioration look operational rather than merely accounting-driven.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 40 / 100
Financial Health Score 40/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Tungray Technologies's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
34

Tungray Technologies has an operating margin of -1.6%, meaning the company retains $-2 of operating profit per $100 of revenue. This results in a moderate score of 34/100, indicating healthy but not exceptional operating efficiency. This is up from -5.1% the prior year.

Growth
48

Tungray Technologies's revenue surged 22.0% year-over-year to $15.6M, reflecting rapid business expansion. This strong growth earns a score of 48/100.

Leverage
55

Tungray Technologies has a moderate D/E ratio of 0.64. This balance of debt and equity financing earns a leverage score of 55/100.

Liquidity
56

Tungray Technologies's current ratio of 1.94 indicates adequate short-term liquidity, earning a score of 56/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
14

While Tungray Technologies generated -$3.0M in operating cash flow, capex of $799K consumed most of it, leaving -$3.8M in free cash flow. This results in a low score of 14/100, reflecting heavy capital investment rather than weak cash generation.

Returns
31

Tungray Technologies's ROE of -0.9% shows moderate profitability relative to equity, earning a score of 31/100. This is up from -3.3% the prior year.

Altman Z-Score Grey Zone
2.87

Tungray Technologies scores 2.87, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/7

Tungray Technologies passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
17.89x

For every $1 of reported earnings, Tungray Technologies generates $17.89 in operating cash flow (-$3.0M OCF vs -$170K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-3.6x

Tungray Technologies earns $-3.6 in operating income for every $1 of interest expense (-$242K vs $66K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$15.6M
YoY+22.0%

Tungray Technologies generated $15.6M in revenue in fiscal year 2025. This represents an increase of 22.0% from the prior year.

EBITDA
$173K
YoY+161.8%

Tungray Technologies's EBITDA was $173K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 161.8% from the prior year.

Net Income
-$170K
YoY+70.2%

Tungray Technologies reported -$170K in net income in fiscal year 2025. This represents an increase of 70.2% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
-$3.8M
YoY-204.6%

Tungray Technologies generated -$3.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 204.6% from the prior year.

Cash & Debt
$6.6M
YoY-26.1%

Tungray Technologies held $6.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
12M

Tungray Technologies had 12M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
45.9%
YoY+2.2pp

Tungray Technologies's gross margin was 45.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the prior year.

Operating Margin
-1.6%
YoY+3.6pp

Tungray Technologies's operating margin was -1.6% in fiscal year 2025, reflecting core business profitability. This is up 3.6 percentage points from the prior year.

Net Margin
-1.1%
YoY+3.4pp

Tungray Technologies's net profit margin was -1.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.4 percentage points from the prior year.

Return on Equity
-0.9%
YoY+2.4pp

Tungray Technologies's ROE was -0.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the prior year.

Capital Allocation

R&D Spending
$975K
YoY-8.3%

Tungray Technologies invested $975K in research and development in fiscal year 2025. This represents a decrease of 8.3% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$799K
YoY+77.4%

Tungray Technologies invested $799K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 77.4% from the prior year.

TRSG Income Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22
Revenue N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A
Net Income N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A

TRSG Balance Sheet

Metric Q4'25 Q4'24 Q4'23 Q4'22
Total Assets $29.5M-1.3% $29.9M+10.6% $27.1M+3.9% $26.0M
Current Assets $18.7M-5.4% $19.8M+6.7% $18.5M+3.7% $17.9M
Cash & Equivalents $6.6M-26.1% $9.0M-17.0% $10.8M-17.7% $13.1M
Inventory $3.4M+51.8% $2.2M-3.4% $2.3M+62.6% $1.4M
Accounts Receivable N/A N/A $320K+205.1% $105K
Goodwill N/A N/A N/A N/A
Total Liabilities $11.5M-9.2% $12.6M+11.6% $11.3M+1.3% $11.2M
Current Liabilities $9.6M-9.0% $10.6M+17.4% $9.0M+8.5% $8.3M
Long-Term Debt N/A N/A N/A N/A
Total Equity $18.0M+4.5% $17.3M+9.8% $15.7M+5.9% $14.8M
Retained Earnings $15.0M-0.1% $15.1M-3.1% $15.5M+5.8% $14.7M

TRSG Cash Flow Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22
Operating Cash Flow N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A

TRSG Financial Ratios

Metric Q4'25 Q4'24 Q4'23 Q4'22
Gross Margin N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A
Current Ratio 1.94+0.1 1.86-0.2 2.05-0.1 2.15
Debt-to-Equity 0.64-0.1 0.73+0.0 0.72-0.0 0.75
FCF Margin N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Tungray Technologies (TRSG) reported $15.6M in total revenue for fiscal year 2025. This represents a 22.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Tungray Technologies (TRSG) revenue grew by 22% year-over-year, from $12.8M to $15.6M in fiscal year 2025.

No, Tungray Technologies (TRSG) reported a net income of -$170K in fiscal year 2025, with a net profit margin of -1.1%.

Tungray Technologies (TRSG) had EBITDA of $173K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Tungray Technologies (TRSG) had a gross margin of 45.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Tungray Technologies (TRSG) had an operating margin of -1.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Tungray Technologies (TRSG) had a net profit margin of -1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Tungray Technologies (TRSG) has a return on equity of -0.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Tungray Technologies (TRSG) generated -$3.8M in free cash flow during fiscal year 2025. This represents a -204.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Tungray Technologies (TRSG) generated -$3.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Tungray Technologies (TRSG) had $29.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Tungray Technologies (TRSG) invested $799K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Tungray Technologies (TRSG) invested $975K in research and development during fiscal year 2025.

Tungray Technologies (TRSG) had 12M shares outstanding as of fiscal year 2025.

Tungray Technologies (TRSG) had a current ratio of 1.94 as of fiscal year 2025, which is generally considered healthy.

Tungray Technologies (TRSG) had a debt-to-equity ratio of 0.64 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Tungray Technologies (TRSG) had a return on assets of -0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Tungray Technologies (TRSG) had $6.6M in cash against an annual operating cash burn of $3.0M. This gives an estimated cash runway of approximately 26 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Tungray Technologies (TRSG) has an Altman Z-Score of 2.87, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Tungray Technologies (TRSG) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Tungray Technologies (TRSG) has an earnings quality ratio of 17.89x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Tungray Technologies (TRSG) has an interest coverage ratio of -3.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Tungray Technologies (TRSG) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top